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Abstract
Background: Treatment failure after radiotherapy of head and neck squamous cell carcinoma
(HNSCC) could be a significant problem. Our objective is to sensitize SCCVII cells to ionizing
radiation  in vitro and  in vivo through inhibiting ATM expression using antisense
oligodeoxynucleotides (AS-ODNs), and investigate the potential mechanism of radiosensitization.
Methods: We designed and synthesized AS-ODNs that target ATM mRNA to reduce the ATM
expression. The influence on the expression of ATM mRNA and protein in SCCVII cells were
analysed by real-time quantitative PCR and western blotting respectively. Clonogenic survival assay
was performed to detect the survival ability of SCCVII cells after irradiation, while flow cytometry
used to analyse the cell cycle and apoptosis. The volume of solid tumors generated with SCCVII
cells was measured, and cell apoptosis was analysed by TUNEL assay after irradiation.
Results: The relative ATM mRNA and protein expression in SCCVII cells treated with ATM AS-
ODNs were decreased to 25.7 ± 3.1% and 24.1 ± 2.8% of that in untreated cells respectively (P <
0.05). After irradiation, the survival fraction (SF) of cells treated with ATM AS-ODNs was lower
than that of other groups at the same dose of radiation (P < 0.05), while the percentage of cells in
G2/M phase decreased and apoptotic rate of cells increased(P < 0.05). The inhibition rate in SCCVII
cells solid tumor exposed to X-ray alone was 23.2 ± 2.7%, while it was 56.1 ± 3.8% in the group
which irradiated in combination with the treatment of ATM AS-ODNs (P < 0.05). The apoptotic
index for the group irradiated in combination with ATM AS-ODNs injection was 19.6 ± 3.2, which
was significantly higher than that of others (P < 0.05)
Conclusion: Inhibition of ATM expression sensitized SCCVII cells to ionizing radiation in vitro and
in vivo. The potential mechanism should be the defective G2/M cell cycle checkpoint control and
enhanced radiation-induced apoptosis.
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Background
Despite advances in surgical treatments, radiotherapy is
superior in its ability to preserve function and appearance
in the treatment of head and neck squamous cell carci-
noma (HNSCC). But some kinds of HNSCC are refractory
to ionizing radiation, which results in the low effective-
ness of radiotherapy alone[1,2]. SCCVII cell line, is a
spontaneously arising head and neck squamous carci-
noma cell line from syngeneic C3H/HeJ mice[3]. An oral
cancer murine model using the SCCVII cell line shares
characteristics such as initial locoregional tumor invasion,
direct extension into the neck, and early cervical metas-
tases with human head and neck tumors[4]. So SCCVII
cell line could be a good object to study the biological
behavior of HNSCC.
One strategy to improve the effectiveness of radiotherapy
is augmenting of tumour radiosensitivity[5]. In the latter
study, SCCVII cells were found to be resistant to ionizing
radiation. The cytotoxicity of ionizing radiation is mainly
mediated through the generation of DNA-double strand
break (DSB) as evidenced by the pronounced radiosensi-
tivity of cells and organisms defective in the machinery of
DSB repair[6-8]. Thus, inhibition of DSB repair provides a
mechanism to enhance the cytotoxicity of IR in tumour
cells. The ataxia-telangiectasia mutated (ATM) protein
kinase is a critical component in these pathways and inte-
grates the cellular response to damage by phosphorylating
key proteins involved in cell cycle regulation and DSB
repair[9,10]. Lack of the normal ATM function in the
inherited ataxia telangiectasia (AT) syndrome results in
the profound hypersensitivity to ionizing radiation[11-
13]. As mentioned elsewhere p53-wild-type cell lines with
dysfunctional ATM, when irradiated, either show a lack of
or delayed activation of p53, resulting in a defective G1/S
cell-cycle checkpoint[14]. However, in p53 mutated cell
lines, disruption of ATM resulted in defective G2/M check-
point control, radio-resistant DNA synthesis, retarded cell
proliferation and enhanced radiosensitivity[15,16].
Therefore, we manage to examine whether reduction of
ATM expression after antisense oligodeoxynucleotides
(AS-ODNs) treatment would result in enhanced radiosen-
sitivity of p53-mutated SCCVII cells from C3H/He mice
through the aberrant G2/M checkpoint.
Methods
Reagents
RPMI-1640 media and 10% heat-inactivated fetal bovine
serum (FBS) were purchased from Gibco Company (Egg-
enstein, Germany). Lipofectamine 2000, Opti-MEM
medium and Trizol kit were bought from Invitrogen Com-
pany(Carlsbad, CA, USA). SYBR ExScript RT-PCR Kit and
SYBR Green Master Mix were purchased from Takara Bio-
technology Company (Dalian, China). ATM monoclonal
antibodies was bought from Santa Cruz Biotechnology
(Santa Cruz, CA, USA), and β-actin monoclonal antibod-
ies from Sigma (St Louis, MO, USA). BCIP/NBT alkaline
phosphatase substrate kit IV was purchased from Vector
laboratories (Burlingame, CA, USA). TUNEL apoptosis
detection kit was bought from Roche Company (Shang-
hai, China)
Cell lines and mice
SCCVII cell line was generously obtained from the labora-
tory of gene therapy at Johns Hopkins University. SCCVII
cells were cultured in complete RPMI-1640 media con-
taining 10% heat-inactivated FBS, 2 mM L-glutamine, 100
IU/mL penicillin, 100 μg/mL streptomycin. Cells were
cultured as a monolayer at 37°C in a humidified atmos-
phere containing 5% CO2. Female C3H/He mice, aged 6–
8 weeks, weighing 18–22 g, were obtained from Vital
River Laboratories (Beijing, China) and were maintained
in the animal facility at West China Medical School,
Sichuan University in accordance with nation's related
regulations and animal welfare requirements.
Synthesis of oligodeoxynucleotides(ODNs) and selection 
of target sequences
A 25-mer AS-ODN which was previously reported to
inhibit ATM expression in mouse cerebrovascular
endothelial cells[17], and its associated controls, sense
(Sen) and mismatch (Mis) ODNs, were synthesized by
Shanghai Sangon Biological Engineering Technology &
Services (Shangai, China). The sequences were as follows:
AS, 5'-GTGCTAGACTCATGGTTTAAGATTT-3'; Sen, 5'-
AAATCTTAAACCATGAGTCTAGCAC-3' and Mis, 5'-
CCCCAGCAGCTCCCATTGGGCGTAA-3'. All the ODNs
were chemically modified to phosphorothioate ODNs by
substituting the oxygen molecules of the phosphate back-
bone with sulfur.
Transfection of ODNs in SCCVII cells
SCCVII cells at a density of 5 × 104 cells/ml were plated for
overnight incubation. Cells were maintained in RPMI-
1640 medium supplemented with 10% FBS at 37°C and
5% CO2. After grew to 80%–90% fill, cells were replen-
ished with incompleted RPMI-1640 medium, then treated
with ATM AS-ODNs, ATM Sen-ODNs and Mis-ODNs. The
procedures were as follows: 200 nM of ATM AS-ODNs,
Sen-ODNs, Mis-ODNs and 2 mg/ml Lipofectamine 2000
were added to Opti-MEM medium separately, and incu-
bated for 5 min at room temperature. Then liposome and
ODNs were mixed together respectively and incubated at
room temperature for 20 min. SCCVII cells were washed
again with Opti-MEM medium before transfection. The
liposome ODNs complexes were carefully plated on the
cells, and incubated at 37°C, 5% CO2. After 6 hours trans-
fected cells were washed twice with PBS, the medium was
replaced with fresh RPMI-1640 medium supplemented
with 10% FBS, cells were incubated at 37°C overnight. AJournal of Experimental & Clinical Cancer Research 2008, 27:56 http://www.jeccr.com/content/27/1/56
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second ODNs incubation was performed before cells were
exposed to radiation.
Real-time quantitative PCR analysis
Total RNAs were extracted from cultured SCCVII cells
using Trizol reagent according to the manufacture's proto-
col. RNA concentration and purity were determined on a
UV spectrophotometer (BioRad Inc., Hercules, CA, USA)
by the 260 nm absorbance and 260–280 nm absorbance
ratio, respectively. Synthesis of cDNA was conducted
using SYBR ExScript RT-PCR Kit according to manufac-
turer's instructions. Real-time quantitative RT-PCR for the
ATM mRNA was performed on an ABI PRISM 7300
Sequence Detection System (Applied Biosystems, Foster
City, CA, USA) using SYBR Green Master Mix. For normal-
ization the gene GAPDH was used. Final reaction volume
is 25 μl. Cycling conditions were as follows: initial dena-
turation at 95°C for 10 s, followed by 40 cycles of 95°C
for 5 s and 59°C for 31 s. Each measurement was per-
formed in triplicate. The gene expression levels obtained
were normalized by mRNA expression of GAPDH. The
relative mRNA expression was then presented in relation
to the untreated control group. All oligonucleotide prim-
ers were designed and synthesized by Sangon (Shanghai,
China). The primer sequences are listed as follows: ATM,
forward, 5'-CCAGGGGAAGATGATGAAGA-3' reverse 5'-
CTACAATGAGCTGCGTGTGG-3'; GAPDH, forward,5'-
CCTCAAGATTGTCAGCAAT-3' reverse, 5'-CCATC-
CACAGTCTTCTGAGT-3'.
Western blot analysis
Total proteins extracted from SCCVII cells were separated
on 10% or 15% SDS-polyacrylamide gels. Fifty micro-
grams each of the preparations were fractionated by
12.5% SDS-PAGE and transferred to nitrocellulose mem-
brane (Millipore, Bedford, MA). The membrane was
blocked with 3% milk powder in PBS at room tempera-
ture for 3 hours, washed with TBS (PBS containing 0.1%
Tween-20) for 10 min three times, then incubated with
the ATM monoclonal antibodies (1:1000 dilution) or β-
actin monoclonal antibodies (1:2000 dilution) in TBS
containing 1% milk powder at 4°C overnight. After three
washes with TBS, the membrane was incubated with alka-
line phosphatase-labeled anti-mouse IgG antibody in TBS
containing 1% milk powder at room temperature for 3
hours and washed again with TBS three times. The mem-
brane was briefly equilibrated with PBS and visualized
with the BCIP/NBT alkaline phosphatases substrate kit IV.
Reactive bands were scanned by Gel Doc 1000 (Bio-Rad).
The experiment was repeated three times.
Irradiation
ELEKTA Precise radiation system (Elekta, Sweden) was
used to irradiate cells and solid tumor. X-ray irradiation
was performed at room temperature at a dose rate of 200
cGy/min and equipped with an external 0.5-mm copper
filter.
Clonogenic survival assay
The SCCVII cells were seeded in triplicate at limiting dilu-
tions in 6-well plates for about 24 hours in RPMI-1640
medium supplemented with 10% FBS until attached.
Then the cells were transfected with ATM AS-ODNs, ATM
Sen-ODNs and Mis-ODNs respectively. About 18 hours
after transfection, they were irradiated with different doses
of X-ray radiation(0, 2, 4, 6, and 8 Gy) respectively. The
medium was replaced with a fresh one 24 hours after irra-
diation. After 7 days of incubation, the colonies were fixed
with methanol, stained with 0.5% crystal violet in abso-
lute ethanol and colonies with >50 cells were counted
under dissection microscope. In each irradiation dose
group, surviving fraction (SF) of cells was calculated as
plating efficiency of the irradiated cells divided by the
plating efficiency of the irradiated cells by that of the
untreated control.
Cell cycle and apoptosis analyzed by flow cytometry
After 48 hours exposed to 2 Gy radiation, cells were har-
vested, and centrifuged at 1500 rpm for 2 min. Then cells
were washed with PBS twice, and fixed with 70% icy-cold
ethanol at 4°C overnight. Cells were stained with PI at
4°C for 30 min. Cell cycle progression and apoptotic rate
were analyzed by flow cytometry (Elite ESP, Beckman
Coulter, USA).
Animal experiment of radiosensitization
Female C3H/He mice were used to investigate the effect of
ATM AS-ODNs on radiosensitivity of SCCVII cells solid
tumor. All surgical procedures and care administered to
the animals were in accordance with institutional guide-
lines. Animal surgeries and radiotherapy were performed
under general anesthesia, 50 mg/kg ip injection of pento-
barbital sodium. About 5 × 106 SCCVII cells were subcuta-
neously inoculated in submental space of the mice.
Tumor growth rates were determined by measuring two
orthogonal dimensional diameters of each tumor twice a
week. Tumour volumes were estimated according to the
formula V = π/6 × a2 × b, where a is the short axis, and b
the long axis. When tumors reached an average volume of
about 200 mm3, the tumor-bearing C3H/He mice were
divided into four groups: (a) control group, no treatment;
(b) ATM AS-ODNs group, tumors were treated with ATM
AS-ODNs alone but not exposed to irradiation for each
time; (c) irradiation group, tumors were exposed to X-ray
of 2 Gy alone for each time; and (d) combination group,
2.5 mg/kg of ATM AS-ODNs was injected into the solid
tumor the day before X-ray exposure, another dosage of
ATM AS-ODNs was injected right before exposure to 2 Gy
of X-ray for each time. The same treatment for each group
were repeated 3 times (the interval time was 5 days). C3H/Journal of Experimental & Clinical Cancer Research 2008, 27:56 http://www.jeccr.com/content/27/1/56
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He mice were killed 3 weeks later. The ATM protein
expression of the tumor in the different groups were anan-
lysed by western blot using the procedures described as
above. The tumor inhibition rate was evaluated using the
following formula: (1-average tumor volume of experi-
mental group/average tumor volume of control group) ×
100%.
Terminal deoxynucleotidyltransferase-mediated dUTP-
digoxigenin nick-end-labeling (TUNEL) assay
TUNEL staining of tumour sections was performed using
an in situ apoptosis detection kit (Roche, Shanghai,
China) according to the manufacture's protocol. The total
number of apoptotic cells in 10 randomly selected fields
was counted. The apoptotic index (AI) was calculated as
the percentage of positive staining cells, namely AI =
number of apoptotic cells × 100/total number of nucle-
ated cells.
Statistics
Results were expressed as mean ± standard deviation(SD).
SPSS12.0 software package was used to perform statistical
analysis. One-way ANOVA test was used to determine sta-
tistical difference between the experimental groups with
others. Differences were considered statistically significant
at P < 0.05.
Results
Expression of ATM in ATM AS-ODNs transfected SCCVII 
cells
We analyzed the expression of ATM in mRNA and protein
level in SCCVII cells using real-time fluorescent quantita-
tive PCR and western blot assay respectively. After 48
hours treatment, there were no significant difference
among the group treated with liposome alone, the group
treated with Sen-ODNs and the group treated with Mis-
ODNs (P > 0.05; Figure. 1). However when incubating
with liposome formulations of ATM AS-ODNs, the rela-
tive ATM mRNA expression was only about 25.7 ± 3.1%
to the untreated SCCVII cells, which demonstrated a sig-
nificantly reduced expression of ATM mRNA (P < 0.05;
Figure. 1). As shown in Figure. 2, ATM protein expression
was also significantly reduced by ATM AS-ODNs com-
pared with Sen-ODNs and Mis-ODNs after 72 hours treat-
ment (Figure. 2A). The relative ATM protein expression of
SCCVII cells treated with ATM AS-ODNs was only about
24.1 ± 2.8% to the untreated cells (P < 0.05; Figure. 2B).
But there was no significant difference among the group
treated with liposome alone, the group treated with Sen-
ODNs and the group treated with Mis-ODNs (P > 0.05;
Figure. 2B).
Effect of ATM AS-ODNs on clonogenic survival ability of 
SCCVII cells after irradiation
Cellular response to ionizing radiation was evaluated by
clonogenic survival assay. Compared with untreated cells
or cells treated with control ODNs, cloning efficiency
declined notably in cells which transfected with ATM AS-
ODNs at the same dose of radiation (Figure. 3). The sur-
vival fraction after 2 Gy (SF2) reflect the cellular intrinsic
radiosensitivity. The SF2 of cells transfected with ATM AS-
ODNs was 53.3 ± 3.1%, definitely lower than that of other
cells, which indicated a significant increase in the radio-
sensitivity (P < 0.05; Figure. 3). There were no obvious dif-
ferences among the other groups about clonogenic
survival ability (P > 0.05; Figure. 3).
Effect of ATM AS-ODNs on apoptosis and cell cycle of 
SCCVII cells after irradiation in vitro
After 2 Gy irradiation, the apoptotic rate in ATM AS-ODNs
transfected cells was 24.7 ± 2.5%, which was higher than
that in Sen-ODNs and Mis-ODNs transfected cells (P <
0.05; Figure. 4). It was also found that cell percentage of
G2/M phase was decreased dramatically in ATM AS-ODNs
transfected cells at 48 hours after 2 Gy irradiation com-
pared with that of other groups(P < 0.05; Figure. 5).
Inhibitory effect of ATM AS-ODNs on tumor growth in 
vivo after irradiation
In the group treated with ATM AS-ODNs alone and the
group irradiated in combination with the treatment of
ATM AS-ODNs, the relative ATM protein expression were
only 63.4 ± 5.6% and 62.1 ± 6.1% to the untreated group
respectively (P < 0.05; Figure. 6). Tumor growth of the
mice in four groups were shown in Figure. 7. The inhibi-
tion rate in SCCVII cells solid tumor exposed to X-ray
alone was 23.2 ± 2.7%, while it was 56.1 ± 3.8% in solid
tumor irradiated in combination with the treatment of
ATM AS-ODNs at the experimental endpoint(P < 0.05;
Figure. 7).
Enhancement of tumour apoptosis by irradiation 
combined with ATM AS-ODNs treatment in vivo
Only small numbers of apoptotic cells were detected by
TUNEL analysis in tumors treated with irradiation alone.
In contrast with irradiation alone, tumor cell apoptosis
was doubled following irradiation in combination with
ATM AS-ODNs treatment (Figure. 8A). Accordingly, the AI
for tumors from ATM AS-ODNs treated mice was 19.6 ±
3.2, significantly higher than that of the other groups (P <
0.05; Figure. 8B).
Discussion
Damage to cellular DNA evokes a wide range of cellular
responses that lead to activation of a variety of genes nec-
essary for cellular survival, delay in cell-cycle progression,
and induction of DNA repair[18-20]. ATM protein is a keyJournal of Experimental & Clinical Cancer Research 2008, 27:56 http://www.jeccr.com/content/27/1/56
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Real-time quantitative PCR analysis of ATM mRNA expression Figure 1
Real-time quantitative PCR analysis of ATM mRNA expression. Reduced expression of ATM mRNA in the presence 
of liposome formulations of ATM AS-ODNs(AS-Lipo) was observed. *P > 0.05, no significantly difference among liposome-
treated group(Lipo), and Sen-ODNs (Sen-Lipo) treated group and Mis-ODNs (Mis-Lipo)treated group. **P < 0.05, compared 
with other groups.
Effect of ATM AS-ODNs on the expression of ATM protein in vitro Figure 2
Effect of ATM AS-ODNs on the expression of ATM protein in vitro. (A) Liposome formulations of ATM AS-ODNs 
significantly reduced the expression of ATM protein compared with other groups. (B) *P > 0.05, no significantly difference 
among liposome-treated group(Lipo), and Sen-ODNs (Sen-Lipo) treated group and Mis-ODNs (Mis-Lipo) treated group. **P < 
0.05, compared with other groups.Journal of Experimental & Clinical Cancer Research 2008, 27:56 http://www.jeccr.com/content/27/1/56
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mediator of the radioprotective machinery inducing a sig-
naling network that is responsible for repair of radiation-
induced damaged DNA and for cellular recovery and sur-
vival [21-23]. Rasheed had found that disruption of the
ATM gene in mice resulted in exquisite sensitivity to low
doses of ionizing radiation[24]. Yin demonstrated that
treatment of mouse cerebrovascular endothelial cells with
ATM AS-ODNs led to specific inhibition of ATM induc-
tion, and increased radiation-induced apoptosis in
vitro[17]. Therefore we designed the experiment to test the
hypothesis whether ATM AS-ODNs could inhibit the
expression of ATM in SCCVII cells and furthermore
increase the radiosensitivity by enhancing radiation-
induced apoptosis in vitro and in vivo.
In the present study, we successfully transfected ATM AS-
ODNs into SCCVII cells using liposome as delivery car-
rier, and detected the inhibitory expression of ATM at
mRNA and protein level in SCCVII cells. We found that
expression of ATM was dramatically reduced after cells
were transfected with ATM AS-ODNs compared with that
Sen-ODNs and Mis-ODNs treated groups, which indi-
cated that the inhibition was specific for the ATM anti-
sense sequence. Then we investigated whether the
reduction of ATM expression resulted in radiosensitiza-
tion in SCCVII cells. The results of clonogenic survival
assay  in vitro demonstrated that the cloning efficiency
declined notably in cells which transfected with ATM AS-
ODNs at the same dose of radiation (P < 0.05) compared
with untreated cells or cells treated with control ODNs.
While the SF2 of cells transfected with ATM AS-ODNs was
53.3 ± 3.1%, definitely lower than that of other cells,
which means the increase of cell intrinsic radiosensitivity.
Furthermore we investigated whether the increased radio-
Survival curves for SCCVII cells after irradiation Figure 3
Survival curves for SCCVII cells after irradiation. Survival fractions at each dose point were normalized to untreated 
cells. * P < 0.05, The mean of SF2 in the cells transfected with ATM AS-ODNs was significantly lower than that of other cells.Journal of Experimental & Clinical Cancer Research 2008, 27:56 http://www.jeccr.com/content/27/1/56
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sensitivity in SCCVII cells was due to the enhanced radia-
tion-induced apoptosis and defective cell-cycle
checkpoint. As we known, in p53 mutated cell lines, ATM
mainly regulates the G2/M checkpoint to arrest cells in G2
phase at the time of irradiation where the radiation-
induced DSBs can be repaired[15,16]. From flow cytome-
try, we found that the cells did not accumulate in the G2/
M phase following irradiation in cells transfected with
ATM AS-ODNs, which mean the reduced ATM expression
resulted in the defective G2/M checkpoint control. More-
over, we found that radiation-induced apoptosis
increased among the cells lack of ATM expression com-
pared with those cells that have impact ATM expression.
In our study, we also investigated the effects of ATM AS-
ODNs on the apoptotic responses to ionizing radiation in
vivo. It was found that the tumors irradiated in combina-
tion with the treatment of ATM AS-ODNs were effective in
controlling tumor growth and showed higher apoptotic
rate. The inhibition rate in the tumors injected with ATM
AS-ODNs before exposure to X-ray was 56.1 ± 3.8%,
whereas it was 23.2 ± 2.7% in tumors exposed to radiation
alone, and a significant difference was found between
these two groups (P < 0.05). The results of TUNEL assay
demonstrated that the apoptotic rate of the tumors irradi-
ated in combination with the treatment of ATM AS-ODNs
was obviously higher than that of control groups. The
results of in vivo experiments indicated that the radiosen-
sitivity of SCCVII cells solid tumors were enhanced by the
The apoptotic rate of SCCVII cells after 2 Gy irradiation Figure 4
The apoptotic rate of SCCVII cells after 2 Gy irradiation. The apoptotic rate (Apo) in ATM AS-ODNs transfected cells 
was higher than that in Sen-ODNs and Mis-ODNs transfected cells after 2 Gy irradiation. * P > 0.05, no significant difference 
among these groups. ** P < 0.05, compared with other groups.Journal of Experimental & Clinical Cancer Research 2008, 27:56 http://www.jeccr.com/content/27/1/56
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treatment of ATM AS-ODNs and related with the
increased radiation-induced apoptosis.
Conclusion
We had demonstrated that the ATM AS-ODNs used in our
study could specificly reduce the ATM expression and fur-
ther result in an increased radiosensitivity in SCCVII cells
in vitro and in vivo. The potential mechanism of radiosen-
sitization related with reduced ATM expression should be
the defective G2/M cell-cycle checkpoint control and
enhanced radiation-induced apoptosis.
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Effect of ATM AS-ODNs on the ATM protein expression in vivo Figure 6
Effect of ATM AS-ODNs on the ATM protein expression in vivo. (A) In the group treated with ATM AS-ODNs alone 
(ATM AS-ODNs treated alone) and the group irradiated in combination with ATM AS-ODNs (ATM AS-ODNs + irradiation), 
the expression of ATM protein were decreased. (B) * P < 0.05, compared with the untreated group and the group irradiated 
alone.
Tumor growth in ATM AS-ODNs treated SCCVII cells in C3H/He mice with or without irradiation Figure 7
Tumor growth in ATM AS-ODNs treated SCCVII cells in C3H/He mice with or without irradiation.Journal of Experimental & Clinical Cancer Research 2008, 27:56 http://www.jeccr.com/content/27/1/56
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The apoptosis of SCCVII cells in vivo after irradiation Figure 8
The apoptosis of SCCVII cells in vivo after irradiation. (A) Apoptotic cells are detected by TUNEL. The nuclei of apop-
totic cells were stained brown as observed under light microscopy (magnification, × 400). (B) The treatment by irradiation in 
combination with ATM AS-ODNs injection enhanced the apoptotic rate of tumor cells. * P < 0.05, there was a significant dif-
ference in the AI of tumors treated with irradiation alone compared with the untreated group and the group treated with ATM 
AS-ODNs alone. ** P < 0.05, compared with the other groups.
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